The effect of food composition on serum testosterone levels after oral administration of Andriol® Testocaps®

Clinical Endocrinology

Volumn 66, Issue 4, 2007, Pages 579-585

  Schnabel, Peter G ^a   Bagchus, Wilma ^a,e   Lass, Holger ^b   Thomsen, Torben ^c   Geurts, T B Paul ^d  

^a NV Organon ^*  (Netherlands)

^b Organon Development GmbH   (Germany)

^c Pharm PlanNet Contract Research GmbH   (Germany)

^d Medical Services Department   (Netherlands)

^e Serono International SA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANDRIOL TESTOCAPS; ARTICAINE; IBUPROFEN; NAPROXEN; TESTOSTERONE; TESTOSTERONE UNDECANOATE; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DRUG ABSORPTION; DRUG FORMULATION; DRUG INDUCED HEADACHE; FATIGUE; FEMALE; FOOD COMPOSITION; FOOD INTAKE; GAS CHROMATOGRAPHY; HUMAN; LOW CALORY DIET; MASS SPECTROMETRY; OPEN STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; SINGLE DRUG DOSE; TESTOSTERONE BLOOD LEVEL; UNSPECIFIED SIDE EFFECT;

AGED; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; DIETARY FATS, UNSATURATED; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; INTESTINAL ABSORPTION; MIDDLE AGED; POSTMENOPAUSE; TESTOSTERONE; TESTOSTERONE CONGENERS;

EID: 33947216862     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02781.x     Document Type: Article

References (25)

1. Nieschlag, E., Mauss, J., Coert, A. & Kicovic, P. (1975) Plasma androgen levels in men after oral administration of testosterone or testosterone undecanoate. Acta Endocrinologica, 79, 366-374.
2. Daggett, P.R., Wheeler, M.J. & Nabarro, J.D.N. (1978) Oral testosterone, a reappraisal. Hormone Research, 9, 121-129.
3. Cunningham, G.R. (2006) Testosterone replacement therapy for late-onset hypogonadism. Nature Clinical Practice, 3, 260-267.
4. Köhn, F.-M. & Schill, W.-B. (2003) A new oral testosterone undecanoate formulation. World Journal of Urology, 21, 311-315.
5. Coert, A., Geelen, J., de Visser, J. & van der Vies, J. (1975) The pharmacology and metabolism of testosterone undecanoate (TU), a new orally active androgen. Acta Endocrinologica, 79, 789-800.
6. Horst, H.J., Höltje, W.J., Dennis, M., Coert, A., Geelen, J. & Voigt, K.D. (1976) Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man. Klinische Wochenschrift, 54, 875-879.
7. Geelen, J., Coert, A., Meijer, R. & van der Vies, J. (1977) Comparison of the metabolism of testosterone undecanoate and testosterone in the gastrointestinal wall of the rat in vitro and in vivo. Acta Endocrinologica, 86, 216-224.
8. Williams, L., Hill, D.P., Davis, J.A. & Lowenthal, D.T. (1996) The influence of food on the absorption and metabolism of drugs: an update. European Journal of Drug Metabolism and Pharmacokinetics, 21, 201-211.
9. Welling, P.G. (1996) Effects of food on drug absorption. Annual Review of Nutrition, 16, 383-415.
10. Frey, H., Aakvaag, A., Saanum, D. & Falch, J. (1979) Bioavailability of oral testosterone in males. European Journal of Clinical Pharmacology, 16, 345-349.
11. Bagchus, W.M., Hust, R., Maris, F., Schnabel, P.G. & Houwing, N.S. (2003) Important effect of food on the bioavailability of oral testosterone undecanoate. Pharmacotherapy, 23, 319-325.
12. Jockenhövel, F., Kaufman, J.M., Mickisch, G.H., Morales, A. & Wang, C. (2005) The good, the bad, and the unknown of late onset hypogonadism: the urological perspective. Journal of Men's Health and Gender, 2, 292-301.
13. Steinijans, V.W. & Diletti, E. (1983) Statistical analysis of bioavailability studies: parametric and nonparametric confidence intervals. European Journal of Clinical Pharmacology, 24, 127-136.
14. Vermeulen, A. & Ando, S. (1979) Metabolic clearance rate and interconversion of androgens and the influence of the free androgen fractions. Journal of Clinical Endocrinology and Metabolism, 48, 320-326.
15. Noguchi, T., Charman, W.N.A. & Stella, V.J. (1985) The effect of drug lipophilicity and lipid vehicles on the lymphatic absorption of various testosterone esters. International Journal of Pharmaceutics, 24, 173-184.
16. Shackleford, D.M., Faassen, W.A., Houwing, N., Lass, H., Edwards, G.A., Porter, C.J.H. & Charman, W.N. (2003) Contribution of lymphatically transported testosterone undecanoate to the systemic exposure of testosterone after oral administration of two Andriol formulations in conscious lymph duct-cannulated dogs. Journal of Pharmacology and Experimental Therapeutics, 306, 925-933.
17. Khoo, S.M., Edwards, G.A., Porter, C.J.H. & Charman, W.N. (2001) A conscious dog model for assessing the absorption, enterocyte-based metabolism and intestinal lymphatic transport of halofrantine. Journal of Pharmaceutical Sciences, 90, 1599-1607.
18. Krauss, R.M., Eckel, R.H., Howard, B., Appel, L.J., Daniels, S.R., Deckelbaum, R.J., Erdman, J.W. Jr, Kris-Etherton, P., Goldberg, I.J., Kotchen, T.A., Lichtenstein, A.H., Mitch, W.E., Mullis, R., Robinson, K., Wylie-Rossett, J., St Jeor, S., Suttie, J., Tribble, D.L. & Bazzarre, T.L. (2000) AHA dietary guidelines. Revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation, 102, 2284-2299.
19. Wittert, G.A., Chapman, I.M., Haren, M.T., Mackintosh, S., Coates, P. & Morley, J.E. (2003) Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. Journal of Gerontology, 58A, 618-625.
20. Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A.B., Phong Mac, R., Lee, M., Yarasheski, K.E., Sinha-Hikim, I., Dzekov, J., Magliano, L. & Storer, T.W. (2005) Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. Journal of Clinical Endocrinology and Metabolism, 90, 678-688.
21. Snyder, P.J., Peachey, H., Hannoush, P., Berlin, J.A., Loh, L., Lenrow, D.A., Holmes, J.H., Dlewati, A., Santanna, J., Rosen, C.J. & Strom, B.L. (1999) Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. Journal of Clinical Endocrinology and Metabolism, 84, 2647-2653.
22. Kenny, A.M., Prestwood, K.M., Gruman, C.A., Marcello, K.M. & Raisz, L.G. (2001) Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. Journal of Gerontology, 56A, M266-M272.
23. Steidle, C., Schwartz, S., Jacoby, K., Sebree, T., Smith, T. & Bachand, R.; North American AA2500 T Gel Study Group (2003) AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function. Journal of Clinical Endocrinology and Metabolism, 88, 2673-2681.
24. Wang, C., Cunningham, G., Dobs, A., Iranmanesh, A., Matsumoto, A.M., Snyder, P.J., Weber, T., Berman, N., Hull, L. & Swerdloff, R.S. (2004) Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. Journal of Clinical Endocrinology and Metabolism, 89, 2085-2098.
25. Nieschlag, E., Swerdloff, R., Behre, H.M., Gooren, L.J., Kaufman, J.M., Legros, J.-J., Lunenfeld, B., Morley, J.E., Schulman, C., Wang, C., Weidner, W. & Wu, F.C.W. (2005) Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. International Journal of Andrology 28, 125-127.